Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inger Ottestad

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Current Oncology (Toronto, Ont.)|November 26, 2025
Parenteral Nutrition in Patients with Incurable Cancer: Exploring the Heterogenous and Non-Randomised Clinical LandscapeMarianne Erichsen, Tora S Solheim, Inger Ottestad, et al.
The British Journal of Nutrition|October 15, 2016
Exchanging a few commercial, regularly consumed food items with improved fat quality reduces total cholesterol and LDL-cholesterol: a double-blind, randomised controlled trialStine M Ulven, Lena Leder, Elisabeth Elind, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 11, 2025
Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints SeriesOlav Dajani, Iain Philips, Ester Kristine Størkson, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 12, 2024
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints seriesOla Magne Vagnildhaug, Trude R Balstad, Inger Ottestad, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 29, 2024
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints seriesMarianne J Hjermstad, Gunnhild Jakobsen, Jann Arends, et al.
Mutation Research. Reviews in Mutation Research|June 4, 2021
The hCOMET project: International database comparison of results with the comet assay in human biomonitoring. Baseline frequency of DNA damage and effect of main confoundersMirta Milić, Marcello Ceppi, Marco Bruzzone, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Current Oncology (Toronto, Ont.)|November 26, 2025
Parenteral Nutrition in Patients with Incurable Cancer: Exploring the Heterogenous and Non-Randomised Clinical LandscapeMarianne Erichsen, Tora S Solheim, Inger Ottestad, et al.
The British Journal of Nutrition|October 15, 2016
Exchanging a few commercial, regularly consumed food items with improved fat quality reduces total cholesterol and LDL-cholesterol: a double-blind, randomised controlled trialStine M Ulven, Lena Leder, Elisabeth Elind, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 11, 2025
Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints SeriesOlav Dajani, Iain Philips, Ester Kristine Størkson, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 12, 2024
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints seriesOla Magne Vagnildhaug, Trude R Balstad, Inger Ottestad, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 29, 2024
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints seriesMarianne J Hjermstad, Gunnhild Jakobsen, Jann Arends, et al.
Mutation Research. Reviews in Mutation Research|June 4, 2021
The hCOMET project: International database comparison of results with the comet assay in human biomonitoring. Baseline frequency of DNA damage and effect of main confoundersMirta Milić, Marcello Ceppi, Marco Bruzzone, et al.
Pageof 4